Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,470.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 2,715.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 71,423
  • Market Cap: £1,643.48m
  • RiskGrade: 128
  • Beta: 1.30

Regulatory News

Total Voting Rights 03-Nov-2025 10:56 RNS
Notification of Major Holdings 14-Oct-2025 16:02 RNS
Notice of AGM 10-Oct-2025 07:00 RNS
Total Voting Rights 01-Oct-2025 09:47 RNS
Director/PDMR Shareholding 25-Sep-2025 16:49 RNS
Director/PDMR Shareholding 24-Sep-2025 11:35 RNS
Director/PDMR Shareholding 19-Sep-2025 14:39 RNS
Director/PDMR Shareholding 17-Sep-2025 12:14 RNS
Director/PDMR Shareholding 11-Sep-2025 12:20 RNS
Additional Listing 08-Sep-2025 16:05 RNS
Preliminary results 04-Sep-2025 07:00 RNS
Accelerated Chinese porcine JV formation 04-Sep-2025 07:00 RNS
Notification of Major Holdings 28-Aug-2025 16:57 RNS
Notification of Major Holdings 19-Aug-2025 15:03 RNS
Notification of Major Holdings 19-Aug-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,470.00p
Change Today 5.00p
% Change 0.20 %
52 Week High 2,715.00
52 Week Low 1,424.00
Volume 71,423
Shares Issued 66.54m
Market Cap £1,643.48m
Beta 1.30
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 05-Nov-2025

Time Volume / Share Price
16:35 830 @ 2,470.00p
16:35 27,639 @ 2,470.00p
16:35 142 @ 2,470.00p
16:35 143 @ 2,470.00p
16:35 142 @ 2,470.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page